Description

3-Hydroxy-3,6-Dimethyl-2,3,3,4,5,8,9,10,10,11,11,11-Dodecahydro-1H-Cyclopenta(A)Anthracene-8-One is a complex polycyclic organic compound with a steroidal-like fused ring structure, serving as a critical advanced pharmaceutical intermediate and a versatile building block in synthetic organic chemistry. Its unique molecular framework makes it valuable for the research and development of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated steroidal or polycyclic architectures. This high-purity intermediate is essential for pharmaceutical manufacturers and R&D laboratories engaged in the synthesis of complex molecules for drug discovery and process development.

Application

• Pharmaceutical Intermediate: A key building block in the multi-step synthesis of novel steroidal or polycyclic active pharmaceutical ingredients (APIs).
• Drug Discovery & Development: Used in medicinal chemistry research for creating and screening new chemical entities with potential therapeutic activity.
• Process Chemistry: Serves as a critical intermediate in scaling up synthetic routes from laboratory to pilot and commercial production.
• Organic Synthesis Research: A valuable substrate for studying complex chemical transformations, such as cyclization, oxidation, and functional group manipulations.
• Fine Chemical Production: Employed in the manufacture of high-value, low-volume specialty chemicals for advanced applications.

Basic Information

Product Name	3-Hydroxy-3,6-Dimethyl-2,3,3,4,5,8,9,10,10,11,11,11-Dodecahydro-1H-Cyclopenta(A)Anthracene-8-One
CAS No.	120542-29-2
Molecular Formula	C21H28O2
Molecular Weight	312.45 g/mol
Synonyms	3-Hydroxy-3,6-dimethyldodecahydro-1H-cyclopenta[a]anthracen-8-one; 1H-Cyclopenta[a]anthracen-8-one, dodecahydro-3-hydroxy-3,6-dimethyl-; 3,6-Dimethyl-3-hydroxyperhydro-1H-cyclopenta[a]anthracen-8-one; Steroidal Ketone Intermediate; Polycyclic Ketone Intermediate; CAS 120542-29-2
EINECS	Contact for details

Quality Control

Our production of 3-Hydroxy-3,6-Dimethyl-2,3,3,4,5,8,9,10,10,11,11,11-Dodecahydro-1H-Cyclopenta(A)Anthracene-8-One adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. The material is subjected to rigorous analytical testing, including HPLC, GC, NMR, and IR spectroscopy, to confirm identity, purity, and the absence of critical impurities. Certificates of Analysis (COA) detailing all specification parameters are provided with each shipment. We support compliance with cGMP standards for pharmaceutical intermediate applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The compound may be light-sensitive and should be handled under appropriate conditions to maintain stability. Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single unknown impurity ≤ 0.5%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.